ロード中...
Dyskinesias Do Not Develop after Chronic Intermittent Levodopa Therapy in Clinically Hemiparkinsonian Rhesus Monkeys
The stable 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian (HP) rhesus monkey model of Parkinson’s disease (PD) has been frequently used to test preclinical experimental therapeutics targeted to treat patients with advanced PD who suffer from motor fluctuations and drug-...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3053121/ https://ncbi.nlm.nih.gov/pubmed/21074478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.parkreldis.2010.10.010 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|